Diagnostic Algorithm for the Rapid and CostEffective Detection of Clostridioides difficile Infection: Comparison between C. DIFF QUIK CHEK COMPLETE and VIDAS GDH & Toxin Assay
10.15263/jlmqa.2020.42.3.130
- Author:
Soo Jin YOO
1
;
Dong Hee WHANG
Author Information
1. Department of Laboratory Medicine, Sanggye Paik Hospital, Inje University College of Medicine, Seoul, Korea
- Publication Type:Original Article
- From:Journal of Laboratory Medicine and Quality Assurance
2020;42(3):130-139
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Background:We evaluated the analytical performance and cost-effectiveness of lateral flow immunoassays (LFIAs) in detecting Clostridioides difficile glutamate dehydrogenase (GDH) antigen and toxin A/B, followed by a rapid nucleic acid amplification test (NAAT).
Methods:A total of 341 unformed stools were tested using a two-step algorithmic approach with C. DIFF QUIK CHEK COMPLETE (QCC) LFIA (TechLab, USA), followed by Xpert C. difficile NAAT (Xpert). The performance of the QCC assay was compared with that of the VIDASC. difficile GDH and toxin A/B assay (bioMérieux, France), an enzyme-linked fluorescence im munoassay. The clinical performance and cost-effectiveness of the diagnostic algorithms using the QCC or VIDAS assays were compared to the results obtained using the Xpert assay alone.
Results:For GDH and toxin detection, the QCC and VIDAS assays dem onstrated an almost perfect agreement, with no significant difference in sensitivity (QCC-GDH, 90.5%; VIDAS-GDH, 91.9%; QCC-toxin, 51.4%; VIDAStoxin, 55.4%) and specificity (QCC-GDH, 92.9%; VIDAS-GDH, 89.1%; QCC-toxin, 100%; VIDAS-toxin, 99.6%), compared to the Xpert. The algorithmic approach (GDH and toxin plus Xpert) increased the sensitivity (QCC, 93.2%; VIDAS, 94.6%) and specificity (QCC, 100%; VIDAS, 99.6%). The algorithmic approach reduced the cost compared to the Xpert alone, and the turnaround time of the QCC was shorter than that of the VIDAS assay.
Conclusions:Simultaneous detection of GDH and toxin A/B, using QCC or VIDAS assays showed comparable sensitivity and specificity when followed by the Xpert assay. The QCC assay is preferable in turnaround time and cost, which are important considerations for laboratories handling smaller number of samples.
